uesday February 29, 8:39 am Eastern Time
Company Press Release
Milestone Scientific, Inc. Announces Approval for the Sale of "The Wand" System in Japan
LIVINGSTON, N.J.--(BUSINESS WIRE)--Feb. 29, 2000--Milestone Scientific, Inc. (AMEX:MS - news) today announced that ``The Wand', a computer controlled, virtually painless injection system and its single use disposable handpiece have been approved for sale in Japan.
Immediately following approval, Milestone's exclusive Japanese distributor, Yoshida Dental Trade Distribution Co. Ltd., placed an initial order for 1,000 system kits. Japan is the world's second largest dental market and Yoshida is one of Japan's largest wholesale dental equipment and product distributors. Yoshida has 400 sales representatives staffing offices located in 44 major cities and its distribution network has agreements with approximately 25% of the more than 600 dental dealers in Japan.
Mitchell Kuhn, President and Chief Operating Officer of Milestone, stated, ``We are pleased to have gained access to the Japanese market for our most important product; a market that prizes highly both advances in dental technology and patient comfort. We are also delighted by the confidence shown in our product by Yoshida, an organization that has the requisite resources, skills and enthusiasm to successfully market and distribute 'The Wand`` system in Japan and to ensure the proper training of dentists in its use. Milestone's entry in the Japanese market is a major advance in our Company's efforts to achieve world-wide distribution and acceptance of 'The Wand``. We believe that sales in Japan can accelerate acceptance and greater use of 'The Wand`` elsewhere as well.'
Milestone Scientific Inc. is the developer, manufacturer and marketer of The Wand (tm), a computer controlled injection system. This precision metered, local anesthetic injection enables virtually painless injections to be administered consistently.
This releases contains certain forward-looking statements which involve known and unknown risks, uncertainties or other factors not under the Company's control, which may cause actual results, performance or achievements of the Company to be materially different from the results, performance or other expectations implied by these forward-looking statements. These factors include, but are not limited to, those detailed in the Company's periodic filings with the Securities and Exchange Commission.
--------------------------------------------------------------------------------
Contact:
Wolfe Axelrod Weinberger Assoc. LLC
Stephen D. Axelrod, CFA
212/370-4500
Fax: 212/370-4505
e-mail: steve@wolfeaxelrod.com
www.wolfeaxelrod.com
or
Milestone Scientific, Inc.
Mitchell G. Kuhn, President and COO
973/535-2717
Fax: 973/535-2829
www.milesci.com |
